NIPAH VIRUS IMMUNOGENS AND THEIR USE
Embodiments of immunogens comprising a multimer of NiV G ectodomains and protein nanoparticles comprising an NiV G ectodomain are provided. Also disclosed are nucleic acids encoding the immunogens and methods of their production. Methods for inducing an immune response in a subject by administering a disclosed immunogen to the subject are also provided. In some embodiments, the immune response treats or inhibits NiV infection in a subject..
| Media Type: |
Electronic Article |
|---|
| Year of Publication: |
2024 |
|---|---|
| Publication: |
2024 |
| Contained In: |
Europäisches Patentamt - (2024) vom: 20. Juni To Main Record - year:2024 |
|---|
| Language: |
English |
|---|
| Contributors: |
GRAHAM BARNEY [Author] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Notes: |
Source: www.epo.org (no modifications made), First posted: 2024-06-20, Last update posted on www.tib.eu: 2024-07-05, Last updated: 2024-07-12 |
|---|
| PatentID: |
epa:US2024197858 |
|---|---|
| Patent number: |
epa:US2024197858 |
| Supporting institution / Project title: |
|
|---|
| PPN (Catalogue-ID): |
EPA006048005 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA006048005 | ||
| 003 | DE-627 | ||
| 005 | 20240712131842.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240712s2024 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA006048005 | ||
| 035 | |a (EPA)epa:US2024197858 | ||
| 035 | |a (EPA)67660473 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a GRAHAM BARNEY |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a NIPAH VIRUS IMMUNOGENS AND THEIR USE |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2024-06-20, Last update posted on www.tib.eu: 2024-07-05, Last updated: 2024-07-12 | ||
| 520 | |a Embodiments of immunogens comprising a multimer of NiV G ectodomains and protein nanoparticles comprising an NiV G ectodomain are provided. Also disclosed are nucleic acids encoding the immunogens and methods of their production. Methods for inducing an immune response in a subject by administering a disclosed immunogen to the subject are also provided. In some embodiments, the immune response treats or inhibits NiV infection in a subject. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a LOOMIS REBECCA |e verfasserin |4 aut | |
| 700 | 0 | |a STEWART-JONES GUILLAUME |e verfasserin |4 aut | |
| 700 | 0 | |a MASCOLA JOHN |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 20. Juni |
| 773 | 1 | 8 | |g year:2024 |g day:20 |g month:06 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/67660473/publication/US2024197858A1?q=US2024197858 |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 20 |c 06 | ||